No evidence for involvement of <it>SDHD </it>in neuroblastoma pathogenesis
<p>Abstract</p> <p>Background</p> <p>Deletions in the long arm of chromosome 11 are observed in a subgroup of advanced stage neuroblastomas with poor outcome. The deleted region harbours the tumour suppressor gene <it>SDHD </it>that is frequently mutated in...
Main Authors: | Roels Frank, Van Roy Nadine, Combaret Valérie, Laureys Geneviève, Nuyts Annick, Smet Jöel, Vandenbroecke Caroline, Hoebeeck Jasmien, Vandesompele Jo, De Preter Katleen, Van Coster Rudy, Praet Marleen, De Paepe Anne, Speleman Frank |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-08-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/4/55 |
Similar Items
-
<it>CADM1 </it>is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
by: Eggert Angelika, et al.
Published: (2008-06-01) -
DREAM target reactivation by core transcriptional regulators supports neuroblastoma growth
by: Bieke Decaesteker, et al.
Published: (2019-03-01) -
N-cadherin in neuroblastoma disease: expression and clinical significance.
by: Tim Lammens, et al.
Published: (2012-01-01) -
Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma
by: Del-Favero Jurgen, et al.
Published: (2010-05-01) -
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.
by: Candy Kumps, et al.
Published: (2013-01-01)